Asimily vs Ordr (2026)
The two KLAS scored challengers, 96.6 against 89.4, and close enough that the axis you weight decides it. Both grade A on interoperability and setting coverage. Asimily leads on the independent rating and on pre purchase device evaluation, assessing risk before a device is even bought. Ordr leads on the machine learning and the enforcement model: behavioural fingerprinting on a stated 100 million plus devices generates segmentation policy from learned behaviour, earning an A on AI centrality where Asimily sits at B, and its autonomy design is the best in the lane, simulating enforcement impact and showing the blast radius before any rule changes with a human gate. That autonomy edge is the substantive one, because automatically isolating a misidentified infusion pump is a patient safety event. If your failure mode is the top independent rating and upstream procurement risk, start with Asimily. If your failure mode is segmentation that stalls on distrust of asset data, start with Ordr.
- The higher independent rating: ranked first in the KLAS 2026 Healthcare IoT Security report at 96.6, against Ordr's reported 89.4 in the same report, the most direct comparison available in this lane.
- Assessment upstream of procurement: pre purchase device evaluation assesses risk before a device is bought, moving security ahead of installation rather than inheriting it afterward, a capability Ordr does not match.
- Cross industry reach with healthcare depth retained, graded A on setting, spanning IoMT, IoT, OT, and IT across medical, laboratory, and general connected fleets.
- The stronger AI centrality case: behavioural fingerprinting on a stated 100 million plus devices generates segmentation policy from learned behaviour rather than templates, graded A against Asimily at B, whose moat is a curated knowledge base.
- The better autonomy design, and it is the axis that matters most here: policies are simulated and the blast radius shown before enforcement with a human gate, graded A against Asimily at B, because isolating a misidentified clinical device automatically is a patient safety event.
- Falsifiable deployment: initial discovery within 48 to 72 hours and enforcement in weeks, with segmentation policy generated and validated against real traffic rather than authored from templates.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Asimily and Ordr are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Asimily | Ordr |
|---|---|---|
| Primary category | Healthcare Cybersecurity | Healthcare Cybersecurity |
| Founded | 2017 | Not recorded |
| Headquarters | Sunnyvale, California, United States | Santa Clara, California, United States |
| Website | asimily.com | ordr.net |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Asimily its top capability grade on several axes, including HIPAA and BAA Posture, FDA and Regulatory Status and EHR and Interoperability Depth. Set against Ordr, Asimily grades higher on HIPAA and BAA Posture, FDA and Regulatory Status and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
The AI Health Index awards Ordr its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and EHR and Interoperability Depth. Set against Asimily, Ordr grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and AI Governance and Bias Disclosure. Its thinnest published disclosure sits on AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
Questions buyers ask
Should we choose Asimily or Ordr?
On the axes where the AI Health Index separates them, Asimily grades higher on HIPAA and BAA Posture, FDA and Regulatory Status and AI Liability and Recourse, and Ordr grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and AI Governance and Bias Disclosure. Ordr leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Asimily and Ordr differ most?
The widest separation the AI Health Index records between Asimily and Ordr is on HIPAA and BAA Posture, where Asimily grades A and Ordr grades B. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Asimily and Ordr grade the same?
The AI Health Index grades Asimily and Ordr the same on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Asimily and Ordr not disclosed?
At the last review, at least one of Asimily and Ordr published thin or absent detail on AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Healthcare Administrative Automation page.
This is the closest pairing in the lane, since both grade A on interoperability and setting coverage and both are KLAS scored, 96.6 against 89.4. The splits are specific: Asimily leads on independent rating and pre purchase evaluation, Ordr on AI centrality and autonomy design, where Ordr's A rests on documented enforcement simulation and a human approval gate.
A source caution on Ordr: it publishes its own comparative rankings of competing platforms, so favourable comparative material from the vendor is self interested and this index relies on it only for Ordr's own product claims. Both are cloud based, both report passive agentless monitoring, and neither publishes a security attestation or pricing.